Adjuvant (Alliance A011401)

Description

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer

This trial is available at multiple Sutter Locations. Please contact one of the following about Study Alliance A011401

San Francisco: ClinicalResearch@sutterhealth.org

Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org

East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org

Sacramento: Isabel Rodrigues-Fong Rodrigi@sutterhealth.org and Kirsten Babski mailto:babskik@sutterhealth.org

Modesto: Delia Massone MassonD@sutterhealth.org and Adrienne Palos PalosA@sutterhealth.org

Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals1@sutterhealth.org

San Mateo:Stephanie Casal CasalSL@sutterhealth.org andBonnie Chan ChanBW@sutterhealth.org

Santa Rosa: PatriciaGrinnell GrinneP@sutterhealth.organd Mohammad Naseem NaseemMK@sutterhealth.org

View study details on ClinicalTrials.gov

Principal Investigator

Oleg I. Krijanovski, M.D., Ph.D.

Recruitment Status

Active, Recruiting
Please note that trial statuses change frequently, for the most up to date information regarding REDI's enrolling studies; please contact the research department at 510-204-4155.

Funder

Alliance for Clinical Trials Oncology

Start Date

February 16, 2017

Related Studies

Breast Cancer Chemoprevention in Primary Care at Geisinger

Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.

Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator